The vaccine is designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above. It will be used to support preventive vaccination in countries most ...

The new vaccine – known during its development ... individuals aged 18 years and older at risk of infection from the Ebola virus. “This is an important step towards relieving the burden ...

And that's the way the Ebola virus vaccine is made. That's where the Dengue vaccine is made. Or do you want to try something that's never been done, which is a messenger RNA or DNA vaccine where ...

Ebola virus disease is a rare but often deadly condition ... These include: There are two types of licensed vaccines available to prevent Ebola in people at risk: Ervebo. This vaccine is ...

The jabs, developed by the Sabin Vaccine Institute initially to treat Ebola, are currently in phase 2 of clinical trials for ...

reported on the development of a preventive vaccine against Ebola, based on adenoviral vectors. In the Ebola virus, envelope glycoproteins (GP) mediate entry into the target cells by facilitating ...

Key ebola virus companies such as Auro Vaccines, INOVIO Pharmaceuticals, RedHill Biopharma Ltd., Emergent BioSolutions, Arisan Therapeutics, TFF Pharmaceuticals, China Immunotech, and others are ...

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that, after priority review, the FDA has granted approval of ERVEBO®, or Zaire Ebola virus vaccine V920 (rVSV∆G-ZEBOV-GP), as ...

Officials confirmed Wednesday suspected German cases of the deadly Marburg virus tested negative, following fears the Ebola-like virus ... There are no vaccines or treatments approved to treat ...

The Ebola virus disease outbreak now ravaging parts of West Africa is the largest on record. In fact, West Africa has seen more cases of the disease in 2014 than have been seen in all other ...